Ziftomenib
Ziftomenib (KO-539) is a potent and selective small molecule inhibitor of the menin-MLL protein interaction. It is used in leukemia research, demonstrating antitumor efficacy in both cellular assays and in vivo models of MLL-rearranged and NPM1-mutant acute myeloid leukemia.
Product Specifications
CAS Number
2134675-36-6
Product Name Alternative
Menin-MLL, Histone Methyltransferase, HistoneMethyltransferase, KO539, KO-539, KO 539, Ziftomenib
Field of Research
Epigenetics & Chromatin
Purity
98.30% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:3.3 mg/mL (4.6 mM) ; DMSO:80 mg/mL (111.44 mM)
Smiles
CNc1nc (NC2CCN (Cc3ccc4n (C[C@H] (C) N5CCN (CC5) S (C) (=O) =O) c (cc4c3C) C#N) CC2) c2cc (CC (F) (F) F) sc2n1
Molecular Formula
C33H42F3N9O2S2
Molecular Weight
717.871
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
40830061 1.0 µg DNA
RPL13P Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)
Sign In for Pricing
View Details GTR15393679 1 Vial
Lentiviral human CHML sgRNA gene knockout kit - Lentiviral human CHML sgRNA gene knockout kit (100)
Sign In for Pricing
View Details 